Why These 5 Stocks Are Trending on Friday

3. Gilead Sciences, Inc. (NASDAQ:GILD) is down 3.65% despite reporting adjusted EPS of $2.65 and sales of $7.4 billion versus the consensus of $1.74 and $6.25 billion for Q3. Given the decline, the market apparently had higher expectations than analysts. 54 funds in our database were long Gilead Sciences, Inc. (NASDAQ:GILD) at the end of Q2.